Healthcare
The shortage isn’t new, although it appears to be hitting more of a crisis point.
Sareum Holdings PLC, the specialist small molecule drug development business notes that Sierra Oncology, the licence holder advancing clinical cancer candidate SRA737, has announced its financial and operational results for the second quarter 2019 ended 30 June 2019.
The Centers for Medicare and Medicaid Services announced the agency would cover CAR-T so patients would have “consistent and predictable access” to the therapy.
Oncoceutics, Inc., announced a collaboration with the National Cancer Institute funded Pediatric Preclinical Testing Consortium to enable tumor type selection for ONC201 clinical trials in pediatric oncology beyond diffuse midline gliomas.
Cyclone® 70 will be used as a high energy, high intensity proton “driver” for a large science project for rare isotopes
Supporting rare disease diagnosis, education, and clinical research
New research among INFORMS members is saving hospitals big bucks.
The project, led by researchers at the Wellcome Sanger Institute and Massachusetts General Hospital, builds on the previous six years’ study, and practically doubles the volume of novel data available on the website – making it the largest public dataset of its kind in the world.
CelGro® Human Nerve Regeneration Trial Recently Orthocell announced that the first four patients successfully completed participation in the CelGro® nerve regeneration clinical trial.
“In the first half of the year, we achieved very strong results, driven by high demand for our new medicines,” stated Severin Schwan, Roche’s chief executive officer.
PRESS RELEASES